$2,470.87 travel Payment -- Pfizer Inc to Dr. Sarah Chen

Cardiologist Sarah Chen Receives $2,470.87 in Travel Payments from Pfizer Inc for Ozempic

This page provides a detailed analysis of a $2,470.87 travel payment from Pfizer Inc to Dr. Sarah Chen. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$2,470.87
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyPfizer Inc
PhysicianDr. Sarah Chen
NPI Number1833917600
Physician SpecialtyCardiology
LocationCity, IN
Date of Payment2025-07-04
Related Drug/DeviceOzempic
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Pfizer Inc made a $2.5K travel payment to Sarah Chen, a Cardiology specialist in City, IN. The payment was associated with Ozempic. Sarah Chen received $2,470.87 from Pfizer Inc for travel and lodging related to Ozempic. The payment occurred on July 4, 2025, indicating a potential connection to industry events or conferences. This payment falls under the 'travel' category, suggesting it covers expenses for attending meetings or educational activities.

Patient Guidance: What This Payment Means for You

If you are a patient, this payment indicates your doctor may have received travel support from a pharmaceutical company for educational purposes related to a specific medication. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For a Cardiology specialty, travel and lodging payments are common for attending medical conferences and educational events, but the amount should be reviewed for appropriateness.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging must be reported under the Sunshine Act to ensure transparency in the relationships between healthcare providers and pharmaceutical companies.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $2.5K payment for?

This was a travel payment of $2.5K from Pfizer Inc to Sarah Chen, categorized as "Travel and Lodging". It was associated with Ozempic. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Sarah Chen accept pharmaceutical money?

Yes, Sarah Chen received this $2.5K payment from Pfizer Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Sarah Chen's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $2.5K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Cardiology?

To compare this payment against Cardiology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Cardiology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Sarah Chen's relationship with Pfizer Inc?

The payment amount is moderate, suggesting it covered specific travel expenses rather than extensive consulting. This $2.5K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Cardiology?

The payment nature is 'Travel and Lodging', clearly defining the purpose of the financial transaction.

What should patients do after learning about this payment?

If you are a patient, this payment indicates your doctor may have received travel support from a pharmaceutical company for educational purposes related to a specific medication.

What else should I know about this travel payment?

Pfizer Inc is the payer, and Ozempic is the associated drug, linking the payment to a specific pharmaceutical product.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.